Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions provide the basis of precision cancer medicine. In this issue of Cancer Discovery, continued progress in this field is dem-onstrated by two large collaborative studies: Horak and colleagues in the MASTER trial for patients with rare cancers and Van Tilburg and colleagues in the INFORM registry in pediatric tumors.
Precision cancer medicine: Large studies indicate steady progress / A. Eggermont, B. Geoerger, G. Curigliano. - In: CANCER DISCOVERY. - ISSN 2159-8274. - 11:11(2021 Nov), pp. 2677-2678. [10.1158/2159-8290.CD-21-1069]
Precision cancer medicine: Large studies indicate steady progress
G. CuriglianoUltimo
2021
Abstract
Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions provide the basis of precision cancer medicine. In this issue of Cancer Discovery, continued progress in this field is dem-onstrated by two large collaborative studies: Horak and colleagues in the MASTER trial for patients with rare cancers and Van Tilburg and colleagues in the INFORM registry in pediatric tumors.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Curigliano Cancer Discovery.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
4.53 MB
Formato
Adobe PDF
|
4.53 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
